The Technical Analyst
Inovalon Holdings, Inc. [INOV]
Exchange: NASDAQ Global Select Sector: Healthcare Industry: Medical - Healthcare Information Services
Inovalon Holdings, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
1.31% $27.72
/ 19 apr 2024 @ 13:05
| RATING 2024-04-19 |
|---|
| S- |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Strong Buy | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/20 | 3/20 | 4/20 | 1/21 | 2/21 | 3/21 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$13.86 (-49.99%) $-13.86 |
| Date: 2024-04-24 |
| Expected Trading Range (DAY) |
|---|
|
$ 27.69 - 27.82 ( +/- 0.24%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2021-11-24 | Teuber William J Jr | Sell | 153 412 | Class A Common Stock |
| 2021-11-24 | Teuber William J Jr | Sell | 15 970 | Class B Common Stock |
| 2021-11-24 | Teuber William J Jr | Sell | 2 305 | Restricted Stock Units |
| 2021-11-24 | Teuber William J Jr | Sell | 14 745 | Employee Stock Option (right to buy) |
| 2021-11-02 | Pulido Mark | Sell | 50 000 | Class A Common Stock |
| INSIDER POWER |
|---|
| 0.00 |
| Last 100 transactions |
| Buy: 451 681 | Sell: 1 248 944 |
Forecast:
14:45 - $27.37
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $27.72 (1.31% ) |
| Volume | 0 mill |
| Avg. Vol. | 0.0007 mill |
| % of Avg. Vol | 0 % |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For INOV
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
INOV
Inovalon Holdings, Inc. provides cloud-based platforms for data-driven healthcare. It operates Inovalon ONE Platform, a cloud-based platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately 988,000 physicians; 522,000 clinical facilities; and approximately 314 million individuals and 53 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.
Last 10 Buy Signals
Latest Press Releases
2024-01-09 14:01:00 - Press Release
Michael Hasbany, Former Inovalon Executive, Joins Healthmine's Advisory Board
Dallas--(business wire)--michael hasbany, formerly of inovalon, will provide analytical insights and strategic guidance to healthmine's product strategy.
2021-11-24 09:45:00 - Press Release
Equity Consortium Led By Nordic Capital And Including Insight Partners Completes Acquisition Of Inovalon
Partnership to advance inovalon's mission of empowering data-driven healthcare partnership to advance inovalon's mission of empowering data-driven healthcare
2021-11-03 07:55:00 - Press Release
Pharmacy Leaders And Technology Innovators Convene Virtually November 8-9, 2021
Industry experts highlight strategies for advancing data sharing and improving pharmaceutical patient care at inovalon's scriptmed® conference industry experts highlight strategies for advancing data sharing and improving pharmaceutical patient care at inovalon's scriptmed® conference
2021-11-01 17:51:00 - Press Release
Shareholder Alert: Levi & Korsinsky, Llp Reminds Investors Of An Investigation Into The Fairness Of The Merger Of Inovalon With Nordic Capital
New york, new york--(newsfile corp. - november 1, 2021) - the following statement is being issued by levi & korsinsky, llp:to: all persons or entities who purchased inovalon ("company") (nasdaq: inov) stock prior to august 19, 2021.you are hereby notified that levi & korsinsky, llp has commenced an investigation into the fairness of the merger of inovalon with nordic capital. under the terms of merger, inovalon stockholders will receive $41.00 per share in cash for...
2021-10-18 17:44:00 - Press Release
Shareholder Alert: Levi & Korsinsky, Llp Reminds Investors Of An Investigation Into The Fairness Of The Merger Of Inovalon With Nordic Capital
New york, new york--(newsfile corp. - october 18, 2021) - the following statement is being issued by levi & korsinsky, llp:to: all persons or entities who purchased inovalon ("company") (nasdaq: inov) stock prior to august 19, 2021.you are hereby notified that levi & korsinsky, llp has commenced an investigation into the fairness of the merger of inovalon with nordic capital. under the terms of merger, inovalon stockholders wi
Latest News
2021-10-18 17:44:00 - Newsfile Corp
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation into the Fairness of the Merger of Inovalon with Nordic Capital
New York, New York--(Newsfile Corp. - October 18, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased Inovalon ("Company") (NASDAQ: INOV) stock prior to August 19, 2021.You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Inovalon with Nordic Capital. Under the terms of merger, Inovalon stockholders wi
2021-10-13 07:55:00 - GlobeNewsWire
Inovalon to Host Virtual Client Congress October 18-19, 2021
Former CMS Administrator Seema Verma, Snowflake CEO Frank Slootman, and Aetna/CVS Chief Medical Officer Dr. Kyu Rhee to Deliver Keynotes on Data-Driven Healthcare
2021-10-12 17:49:00 - PRNewsWire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates HOMB, KRA, EBMT, ESBK, INOV; Shareholders are Encouraged to Contact the Firm
NEW YORK, Oct. 12, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Home BancShares, Inc. (NASDAQ: HOMB) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Happy Bancshares, Inc. Under the terms of the definitive merger agreement, Happy Bancshares shareholders will receive 2.17 shares of Home BancShares stock for each share of Happy Bancshares they own and will begin receiving quarterly dividends declared by Home BancShares. If you are a Home BancShares shareholder, click here to learn more about your rights and options.
2021-09-27 08:01:00 - Business Wire
INOVALON INVESTOR ALERT (INOV) - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Inovalon Holdings, Inc.
WILMINGTON, Del.--(BUSINESS WIRE)--Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Inovalon Holdings, Inc. (NASDAQGS: INOV) (“Inovalon” or the “Company”) relating to the sale of the Company to a consortium of investors composed of, among others, Nordic Capital and Inovalon's CEO and founder Keith Dunleavy, M.D. (the “Investor Conso
2021-09-21 10:00:00 - PRNewsWire
CorEvitas and Inovalon Leverage Advanced Analytics to Deliver A Holistic View of the Patient
WALTHAM, Mass., Sept. 21, 2021 /PRNewswire/ -- CorEvitas, LLC, the gold-standard leader in longitudinal real-world data in autoimmune and inflammatory diseases, today announced that it has expanded its engagement with Inovalon's (NASDAQ: INOV) life sciences business unit specializing in data-driven healthcare analytics and strategic advisory services, to provide a holistic view of patients with rheumatoid arthritis or psoriasis.
2021-09-17 16:18:00 - Business Wire
Shareholder Alert: Robbins LLP Announces Acquisition of Inovalon Holdings, Inc. (INOV) by Nordic Capital and Others (Private) May Not Be in Shareholders' Best Interests
SAN DIEGO & BOWIE, Md.--(BUSINESS WIRE)---- $INOV #acquisition--Acquisition of Inovalon Holdings, Inc (INOV) by Nordic Capital and Others May Not Be in Shareholders' Best Interests
2021-08-31 11:33:00 - Newsfile Corp
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of Inovalon with Nordic Capital
New York, New York--(Newsfile Corp. - August 31, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased Inovalon ("Company") (NASDAQ: INOV) stock prior to August 19, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Inovalon with Nordic Capital. Under the terms of merger, Inovalon stockholders will receive $41.00 per share in cash for...
2021-08-30 08:01:00 - Business Wire
INOVALON (INOV) SHAREHOLDER ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Inovalon Holdings, Inc.
WILMINGTON, Del.--(BUSINESS WIRE)--Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Inovalon Holdings, Inc. (NASDAQGS: INOV) (“Inovalon” or the “Company”) relating to the sale of the Company to a consortium of investors composed of, among others, Nordic Capital and Inovalon's CEO and founder Keith Dunleavy, M.D. (the “Investor Conso
2021-08-27 08:02:00 - Newsfile Corp
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Inovalon Holdings, Inc. (INOV) and Encourages Shareholders to Contact the Firm
Philadelphia, Pennsylvania--(Newsfile Corp. - August 27, 2021) - Kaskela Law LLC is investigating Inovalon Holdings, Inc. ("Inovalon" or the "Company") (NASDAQ: INOV) on behalf of the company's stockholders.On August 9, 2021, Inovalon announced that it had entered into an agreement to be acquired by an equity consortium led by Nordic Capital. Under the terms of the proposed agreement, Inovalon stockholders are expected to receive $41.00 per share in cash for each share of INOV...
2021-08-19 17:04:00 - Business Wire
INOVALON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inovalon Holdings, Inc. - INOV
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Inovalon Holdings, Inc. (NasdaqGS: INOV) to an equity consortium led by Nordic Capital. Under the terms of the proposed transaction, shareholders of Inovalon will receive only $41.00 in cash for each share of Inovalon Class A Common Stock or Class B Common Stock that they own. KSF is seeking to determine wheth